지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Regulation and Regulators of the Hippo-YAP/TAZ Pathway
한국생물공학회 학술대회
2016 .10
The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
BMB Reports
2017 .01
Clinical implications of the Hippo-YAP pathway in multiple cancer contexts
BMB Reports
2018 .01
Regulation of Hippo signaling by actin remodeling
BMB Reports
2018 .01
Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation
BMB Reports
2017 .01
Hippo-YAP/TAZ signaling in angiogenesis
BMB Reports
2018 .01
DNA binding partners of YAP/TAZ
BMB Reports
2018 .01
Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
BMB Reports
2017 .06
The history and regulatory mechanism of the Hippo pathway
BMB Reports
2018 .01
Regulation of the Hippo signaling pathway by ubiquitin modification
BMB Reports
2018 .01
A novel role of Hippo-Yap/TAZ signaling pathway in lymphatic vascular development
BMB Reports
2021 .01
The potential role of YAP in head and neck squamous cell carcinoma
Experimental and Molecular Medicine
2020 .08
Dishevelling Wnt and Hippo
BMB Reports
2018 .01
Marine Sponge-Derived Spicule-Enhanced Injectable Hydrogel: Dual-Level Mechanochemical Regulation and YAP/TAZ Pathway Activation for Enhanced Bone Regeneration
한국생물공학회 학술대회
2024 .09
Overcoming BRAF and CDK4/6 inhibitor resistance by inhibiting MAP3K3-dependent protection against YAP lysosomal degradation
Experimental and Molecular Medicine
2024 .04
Roles of YAP in mediating endothelial cell junctional stability and vascular remodeling
BMB Reports
2015 .01
Hippo signaling: Special issue of BMB Reports in 2018
BMB Reports
2018 .01
YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior
Experimental and Molecular Medicine
2021 .06
The interaction between the gut microbiota and dietary carbohydrates in nonalcoholic fatty liver disease
Experimental and Molecular Medicine
2021 .05
0